GLG News Analyses of the following article:
Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
Published at: pharmalive.com
-
Addition of meningococcal vaccine for younger children won't add much value
October 29, 2007
-Menactra recently gained approval for children 2-10 years old -Unless the ACIP changes its recommended age for routine use (currently 11), this will have little impact -Most children will only need this in this expanded age range for travel to some parts of the world.
-
Enlarging the indicated age range may not be a completely beneficial thing
October 26, 2007
Meningococcal disease is rare but devastating, and any available method for reduction of the disease is welcome.
- Subscribe to Updates
-
Work for one of the world's leading organizations? Get started now.
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 9 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.